Entourage Effect Capital
VC Fund
Entourage Effect Capital is a VC fund focused on Cannabis and Biotechnology. Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a private investment firm, dedicated to investing in the cannabis industry. EEC’s mission is to actively leverage our sector and investment experience, networks, and investment process, and to identify, invest and accelerate high quality emerging growth companies. EECstands apart by taking an active role in adding value to the management teams of its companies. Some have called it a “Keiretsu”, but as we are in Cannabis, we call it “the Entourage Effect.” The Entourage Effect is a term used to describe a novel method of endocannabinoid regulation. It means that the compounds within the cannabis plant work in concert to create a sum greater than any of its individual parts. This is the same strength they bring to investing. From early stage acceleration, to acquisition sourcing, to strategy, to creating exit opportunities, they believe in being the most valuable names on their founder’s cap tables.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Entourage Effect Capital invests in
Stages Entourage Effect Capital invests in
Countries Entourage Effect Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $5M–$12M
- Series B
- $9M–$30M
- Venture - Series Unknown
- $7.6M–$20M
Investment Focus
Industry
- Cannabis 5 (56%)
- Biotechnology 4 (44%)
- Health Care 2 (22%)
- Sustainability 2 (22%)
- Alternative Medicine 2 (22%)
Stage
- Series A 3 (33%)
- Series B 3 (33%)
- Venture - Series Unknown 2 (22%)
- Seed 1 (11%)
Country
- United States 7 (78%)
- New Zealand 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dov Szapiro
Co-Founder I Co-Managing Partner
|
Co-Founder I Co-Managing Partner | Total investments: 2 | Find email | |
Matt Hawkins
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 1 | Find email | |
Andrew Sturner
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hoodie Analytics
|
Hoodie Analytics was founded on the belief that cannabis businesses need deeper, operational insights to better compete. Our team has decades of experience in cannabis as well as e-commerce intelligence & market measurement in markets like CPG & FMCG.With Hoodie Analytics, you get an indispensable partner tracking the movements of themarket. You get access to the best people, processes, and data which deliver an unfair advantage over the the competition. You can focus on running your business. We’ll deliver the insights needed to outgrow the pack. | $5M / Series A / Jun 27, 2024 | |
Botanica Seattle
|
Botanica Seattle specializes in the production of natural and handmade cannabis edibles. Its products include mixed fruit chews, chocolate pattie, infused cannabis oil, and cannabis mint made from an alcohol-based extraction process with multiple stages of quality control to guarantee accurate and consistent dosing during final formulation,enabling people to enjoy the taste of handmade cannabis product.The company was founded in 2013 and is headquartered in Seattle, Washington. | $9M / Series B / Jul 13, 2023 | |
Cookies
|
Cookies Inc., is a cannabis brand, which currently has 7 dispensaries in California, 1 in Detroit. | Series A / Apr 11, 2023 | |
BioLumic
|
BioLumic develops light signals that activate plant growth and unlock the natural genetic potential of crops. The company's photogenics platform leverages innovation in plant science, light technology and genetic insights. Demonstrated results include higher yield, improved vigor, increased disease and pest resistance, and improvements incrops composition. These results have been across a variety of seeds and seedling: soybean, cannabis and vegetable and fruit crops. It is a clean technology that does not require the use of chemicals or amendments. BioLumic is a private company and was founded in 2013. | $13.5M / Series B / Jun 21, 2022 | |
|
Hoodie Analytics
|
Hoodie Analytics was founded on the belief that cannabis businesses need deeper, operational insights to better compete. Our team has decades of experience in cannabis as well as e-commerce intelligence & market measurement in markets like CPG & FMCG.With Hoodie Analytics, you get an indispensable partner tracking the movements of themarket. You get access to the best people, processes, and data which deliver an unfair advantage over the the competition. You can focus on running your business. We’ll deliver the insights needed to outgrow the pack. | Seed / Apr 04, 2022 | |
Phylos
|
Phylos is an agricultural genomics company using modern molecular genetics and computational biology to power the next generation of hemp and cannabis. Phylos provides breeding and R&D services to global partners and offers a suite of genetic services and testing solutions. We remain committed to a sustainable cannabis industry and to thepreservation of genetic diversity through the Phylos Galaxy and publicly accessible data, like the Open Cannabis Project.We are a new generation of plant scientists, transforming the hemp and cannabis industries with unparalleled data, technology, and expertise. Phylos is strategically positioned to provide cultivators with the tools to understand the breadth of genetics in their catalog, evaluate the development of additional varieties, and drive business growth. | $7.6M / Venture - Series Unknown / Feb 01, 2022 | |
Cellibre
|
Cellibre is a cellular agriculture company that turns cells into specialized, sustainable factories for the manufacture of globally significant products at scale. | $11.5M / Series A / Oct 13, 2021 | |
Hound Labs
|
Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement. Utilizing this groundbreaking technology, the HOUND MARIJUANA BREATHALYZER is the world’s first breathalyzer to rapidly, accurately, and inexpensively measure recent marijuana use and alcohol in a person’s breath. The HOUNDBREATHALYZER is intended for law enforcement, employer, and insurance purposes only. Founded in 2014, the Oakland-based company was created by Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, his co-founder, Mr. Kuni Oh, a patent attorney with a deep background in engineering and science, and his co-founder, Ms. Jenny Lynn, a business executive with twenty years of experience launching new ventures. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company. | $20M / Venture - Series Unknown / Sep 03, 2021 | |
Semasio (formerly Fyllo)
|
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI.The company was founded in 2019 and isheadquartered in Chicago, Illinois. | $30M / Series B / Apr 06, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Entourage Effect Capital invest in?
Entourage Effect Capital invests primarily in Cannabis, Biotechnology and Health Care startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Entourage Effect Capital's check size?
Entourage Effect Capital typically joins rounds of $5M–$12M at Series A, $9M–$30M at Series B and $7.6M–$20M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Entourage Effect Capital participates in.
How do I contact Entourage Effect Capital?
Public channels for Entourage Effect Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Entourage Effect Capital?
The team at Entourage Effect Capital includes Dov Szapiro (Co-Founder I Co-Managing Partner), Matt Hawkins (Founder & Managing Partner) and Andrew Sturner (Co-Founder & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
